RxDoctor Payments Data

Maya Valentin

Family · Latham, NYNPI 1295453454

Payments from drug & device makers

$658in general payments, 2019–2025

Across 30 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$141
  • Astellas Pharma US Inc$125
  • Biogen$104
  • Novo Nordisk$87
  • Bayer$63
  • Millicent US Inc$44
  • plus $93 from 4 others

What the payments were for

  • Food & beverage$658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$658 in reported general payments places this provider in the 65th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$1,772
Medicare patients
38
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol48$3,985
Metronidazole12$273
Norethindrone14$57

Paid to pharmacies, not to this prescriber.

Other family in Latham

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →